Cite
HARVARD Citation
Doi, T. et al. (n.d.). 659PAvelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial. Annals of oncology. p. . [Online].